eiq_root | Canadian Healthcare Network

ARTICLES BY THIS AUTHOR

11/4/2013
Scene: Honouring Gairdner recipients
11/4/2013
The Medical Post table of contents: November 5, 2013 print edition
11/4/2013
Recognition for military doctors
11/4/2013
Halifax nursing home owner and manager face neglect trial
11/4/2013
Communication problems plague transfers and handovers
Patient safety is being put at risk, according to staff and residents
11/4/2013
New option for pancreatic cancer
11/4/2013
What your patients are reading - Week of November 4, 2013
11/4/2013
The age-old question of mandatory retirement
Should age—or skills—mandate retirement?
11/4/2013
Intuniv XR: first alpha agonist approved for ADHD
Shire Canada is introducing Intuniv XR (guanfacine 1 mg, 2 mg, 3mg, and 4 mg extended-release tablets), the first selective alpha2A-adrenergic receptor agonist to be approved for the treatment of attention deficit hyperactivity disorder (ADHD) in Canada.
11/4/2013
Nurses’ union cites poor conditions